Cargando…

Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients

OBJECTIVE: We examined the effects of fixe-dose combinations (FDCs) versus loose-dose combinations (LDCs) on costs from the payer and patient perspective and investigated potential channels contributing to differences in costs between the two modes of treatment. METHODS: We investigated administrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böhm, Anna-Katharina, Schneider, Udo, Stargardt, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834204/ https://www.ncbi.nlm.nih.gov/pubmed/36310297 http://dx.doi.org/10.1007/s40258-022-00760-x

Ejemplares similares

Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes
por: Böhm, Anna-Katharina, et al.
Publicado: (2021)

Fixed Dose Versus Loose Dose: Analgesic Combinations
por: Pergolizzi, Joseph, et al.
Publicado: (2023)

Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study
por: Aoki, Kazutaka, et al.
Publicado: (2017)

A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects
por: Kim, Eunwoo, et al.
Publicado: (2019)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming, Joshua W, et al.
Publicado: (2015)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
por: Reynolds, Jonathan K
Publicado: (2009)

Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects
por: Jin, Xuanyou, et al.
Publicado: (2020)

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
por: Davidson, Jaime A., et al.
Publicado: (2016)

Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
por: Derosa, Giuseppe, et al.
Publicado: (2007)

Fixed-dose combination antihypertensives and risk of medication errors
por: Moriarty, Frank, et al.
Publicado: (2019)

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
por: Rhee, Su-jin, et al.
Publicado: (2016)

Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects
por: Yang, Eunsol, et al.
Publicado: (2019)

Fixed dose combinations in diabetes: Indian innovation, Indian pride
por: Kalra, Sanjay, et al.
Publicado: (2012)

The renaissance of fixed dose combinations: Combivir
por: Portsmouth, Simon D, et al.
Publicado: (2007)

Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis
por: Akazawa, Manabu, et al.
Publicado: (2013)

Spillover adherence effects of fixed-dose combination HIV therapy
por: Kauf, Teresa L, et al.
Publicado: (2012)

Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination
por: Fuwa, Masahiro, et al.
Publicado: (2016)

Efficacy and Safety of ‘Fixed Dose’ versus ‘Loose’ Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial
por: Aseffa, Abraham, et al.
Publicado: (2016)

Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis
por: Wei, Qiran, et al.
Publicado: (2023)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
por: Hayes, Jennifer, et al.
Publicado: (2016)

Real-World Evidence of User Engagement With Mobile Health for Diabetes Management: Longitudinal Observational Study
por: Böhm, Anna-Katharina, et al.
Publicado: (2020)

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Fixed-dose combinations: An essential for rational preparation
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses, Robert G
Publicado: (2010)

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
por: Farsang, Csaba
Publicado: (2014)

Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review
por: Kedia, Rohit, et al.
Publicado: (2016)

Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
por: Kalra, Sanjay, et al.
Publicado: (2020)

Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis
por: Gallardo, Carmen R, et al.
Publicado: (2016)

Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
por: Canbakan, Başol
Publicado: (2013)

Outcome of radioiodine therapy for feline hyperthyroidism: Fixed dose versus individualized dose based on a clinical scoring system
por: Matos, Joana, et al.
Publicado: (2022)

A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies
por: He, Jimmy Zhijian, et al.
Publicado: (2022)

Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
por: Al-Shaer, Mohammad H., et al.
Publicado: (2017)

Fixed Dose Combination of Arterolane and Piperaquine: A Newer Prospect in Antimalarial Therapy
por: Patil, CY, et al.
Publicado: (2014)

Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
por: Moitra, Subhabrata, et al.
Publicado: (2015)

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis
por: Kawalec, Paweł, et al.
Publicado: (2018)

Too bad! Fixed dose combination antiretroviral drugs
por: Agyarko-Poku, Thomas, et al.
Publicado: (2014)

Fixed dose drug combinations: Issues and challenges in India
por: Gupta, Yogendra Kumar, et al.
Publicado: (2016)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
por: Derom, Eric, et al.
Publicado: (2016)

The Facts and Fiction of Olanzapine-Samidorphan Fixed Dose Combination
por: Das, Nileswar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7aq663hj759hd45nkmo28bnn7c